Hauck & Aufhaeuser Reiterates €14.00 Price Target for Aumann (ETR:AAG)

Share on StockTwits

Hauck & Aufhaeuser set a €14.00 ($16.28) target price on Aumann (ETR:AAG) in a report issued on Wednesday morning, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

Separately, Berenberg Bank set a €17.50 ($20.35) price target on Aumann and gave the company a neutral rating in a research report on Thursday, July 18th.

Shares of ETR AAG opened at €15.72 ($18.28) on Wednesday. Aumann has a one year low of €12.20 ($14.19) and a one year high of €65.30 ($75.93). The company has a debt-to-equity ratio of 11.43, a current ratio of 3.24 and a quick ratio of 2.99. The business’s fifty day moving average price is €14.30 and its 200-day moving average price is €22.50. The stock has a market capitalization of $239.73 million and a PE ratio of 14.89.

Aumann Company Profile

Aumann AG manufactures and sells specialized machines and production lines for components of electric and classic drive chain systems in the United States, Canada, Mexico, Europe, China, and internationally. It operates through E-Mobility and Classic segments. The E-Mobility segment designs, manufactures, and distributes specialized machines and automated production lines for the automotive, aerospace, rail, and other mobility industries; solutions to produce electric motors and mechatronic modules for traction and auxiliary drives, and sensors; and special-purpose machinery and production lines for the production of electric and hybrid vehicles, including energy storage systems.

Featured Article: Dividend Reinvestment Plan (DRIP)

Receive News & Ratings for Aumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aumann and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Dunelm Group  Stock Rating Upgraded by Peel Hunt
Dunelm Group Stock Rating Upgraded by Peel Hunt
Barclays Downgrades Ferrexpo  to Underweight
Barclays Downgrades Ferrexpo to Underweight
UBS Group Reaffirms “Neutral” Rating for Halma
UBS Group Reaffirms “Neutral” Rating for Halma
Schneider National  Raised to Buy at UBS Group
Schneider National Raised to Buy at UBS Group
Investment Analysts’ Recent Ratings Updates for Mirati Therapeutics
Investment Analysts’ Recent Ratings Updates for Mirati Therapeutics
Sunoco  Upgraded at ValuEngine
Sunoco Upgraded at ValuEngine


 
© 2006-2019 Zolmax.